Deler fremragende | 172,573,545 shares |
Insideraktier | 447.585.264 shares |
Total Insiders | 25 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
Inhibitor Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
---|---|---|---|
Black Robe Capital LLC
10% Owner -
|
40.202.114 | 40.202.114 | |
James D Causey Director - [D] | 1.000 | 1.000 | |
Stefan Cross Director - [D] | 0 | 0 | |
Peter C Einselen | 3.000 | ||
Richard J Freer
Chief Executive Officer, Director, 10% Owner -
[D]
[O]
|
7.485.141 | 7.485.141 | |
Hasara Garrison J. CFO and Treasurer - [O] | 3.972.544 | 3.972.544 | |
HedgePath, LLC
10% Owner -
|
79.627.069 | 79.627.069 | |
Michael Allen Jerman Director - [D] | 80.411 | 80.411 |
Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
---|---|---|---|
Gerald P Krueger Director - [D] | 0 | 0 | |
Magrab E. Brendan Director - [D] | 65.000 | 65.000 | |
James A Mcnulty
10% Owner -
|
1.946.135 | 1.946.135 | |
Robert Daniel Martin Director - [D] | 116.000 | 116.000 | |
Pharma Group Ltd Mayne
10% Owner -
|
204.083.227 | 204.083.227 | |
Pharma Ventures Pty Ltd Mayne
Director, 10% Owner -
[D]
|
204.083.227 | 204.083.227 | |
Francis E Jr Odonnell
See Remarks, Director, 10% Owner -
[D]
[O]
|
85.627.069 | 85.627.069 | |
Ronald E Osman
Director, 10% Owner -
[D]
|
23.554.985 | 23.554.985 |
Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
---|---|---|---|
Richard Dana Ono Director - [D] | 453.000 | 453.000 | |
Debra Peattie | 580.646 | ||
Ronald E Osman Irrevocable Trust III
10% Owner -
|
23.489.985 | 23.554.985 | |
Samuel P Jr Sears Director - [D] | 1.279.543 | 1.279.543 | |
Tpb 2012 Llc
10% Owner -
|
28.616.250 | 28.616.250 | |
Nicholas J Virca President and CEO - [O] | 8.727.519 | 8.727.519 | |
Niraj Vasisht | 0 | ||
Watson W. Mark Director - [D] | 1.054.100 | 1.054.100 | |
Michelle Yanez Director - [D] | 896.271 | 896.271 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i INTI / Inhibitor Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i INTI / Inhibitor Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-04-10 | 2025-04-01 | 4 | Vasisht Niraj | INTI | Common Stock | D | 50.000 | |||||||
2025-04-07 | 2025-04-01 | 4 | Yanez Michelle | INTI | Common Stock | D | 50.000 | 896.271 | ||||||
2025-04-07 | 2025-04-01 | 4 | SEARS SAMUEL P JR | INTI | Common Stock | D | 50.000 | 1.279.543 | ||||||
2025-04-07 | 2025-04-01 | 4 | OSMAN RONALD E See Footnotes | INTI | Common Stock | I | 50.000 | 23.554.985 | ||||||
2025-04-07 | 2025-04-01 | 4 | Jerman Michael Allen | INTI | Common Stock | D | 50.000 | 80.411 | ||||||
2025-02-19 | 2024-12-02 | 5 | MCNULTY JAMES A | INTI | Common Stock | D | 1.000.000 | 1.946.135 | ||||||
2025-02-19 | 2024-12-02 | 5 | Yanez Michelle | INTI | Common Stock | D | 250.000 | 1.146.271 | ||||||
2024-05-16 | 2024-04-01 | 4 | Jerman Michael Allen | INTI | Common Stock | D | 50.000 | 80.411 | ||||||
2024-05-16 | 2024-04-01 | 4 | OSMAN RONALD E Seefootnote | INTI | Common Stock | I | 50.000 | 23.564.985 | ||||||
2024-05-16 | 2024-04-01 | 4 | SEARS SAMUEL P JR | INTI | Common Stock | D | 50.000 | 1.129.543 | ||||||
2024-05-16 | 2024-04-01 | 4 | Yanez Michelle | INTI | Common Stock | D | 50.000 | 896.271 | ||||||
2023-08-29 | 2023-08-11 | 4 | OSMAN RONALD E | INTI | Common Stock | D | 25.000 | 23.514.985 | ||||||
2023-08-29 | 3 | Ronald E Osman Irrevocable Trust III | INTI | Common Stock | D | 23.489.985 | ||||||||
2023-05-22 | 3 | Donovan James Joseph III | INTI | Common Stock | D | 349.500 | ||||||||
2023-05-22 | 3 | Donovan James Joseph III | INTI | Common Stock | I | 27.917.250 | ||||||||
2023-05-17 | 2023-05-05 | 4 | MCNULTY JAMES A | INTI | Common Stock | I | 20.101.057 | 26.101.057 | ||||||
2023-05-17 | 2023-05-05 | 4 | MCNULTY JAMES A | INTI | Common Stock | D | 398.135 | 946.135 | ||||||
2023-05-17 | 2023-05-05 | 4 | MCNULTY JAMES A | INTI | Common Stock | I | -79.627.069 | 0 | ||||||
2023-05-17 | 3 | MCNULTY JAMES A | INTI | Common Stock | D | 20.101.057 | ||||||||
2023-05-17 | 2023-05-05 | 4 | Yanez Michelle | INTI | Common Stock | D | 796.271 | 800.673 | ||||||
2022-12-22 | 3 | SEARS SAMUEL P JR | INTI | Common Stock | D | 969.096 | ||||||||
2022-12-22 | 3 | ODONNELL FRANCIS E JR See Footnotes | INTI | Common Stock | I | 85.627.069 | ||||||||
2022-12-22 | 3 | Yanez Michelle | INTI | Common Stock | D | 4.402 | ||||||||
2022-12-22 | 3 | MCNULTY JAMES A See Footnotes | INTI | Common Stock | I | 85.627.069 | ||||||||
2022-12-22 | 3 | MCNULTY JAMES A | INTI | Common Stock | D | 548.000 | ||||||||
2021-01-19 | 2021-01-15 | 4 | Mayne Pharma Ventures Pty Ltd | INTI | Common Stock | D | 2.240.488 | 204.083.227 | ||||||
2020-12-28 | 2020-12-22 | 4 | Watson W. Mark | INTI | Common Stock Option | D | 0,03 | 1.306.452 | 1.306.452 | |||||
2020-12-28 | 2020-12-22 | 4 | Martin Robert Daniel | INTI | Common Stock Option | D | 0,03 | 754.839 | 754.839 | |||||
2020-12-28 | 2020-12-22 | 4 | VIRCA NICHOLAS J | INTI | Common Stock Option | D | 0,03 | 125.000 | 125.000 | |||||
2020-12-28 | 2020-12-22 | 4 | Peattie Debra | INTI | Common Stock Option | D | 0,03 | 580.646 | 580.646 | |||||
2020-12-28 | 2020-12-22 | 4 | Hasara Garrison J. | INTI | Common Stock Option | D | 0,03 | 125.000 | 125.000 | |||||
2020-12-28 | 2020-12-22 | 4 | Ono Richard Dana | INTI | Common Stock Option | D | 0,03 | 754.839 | 754.839 | |||||
2020-09-21 | 2020-09-17 | 4 | VIRCA NICHOLAS J | INTI | Common Stock Option | D | 0,05 | 100.000 | 100.000 | |||||
2020-09-21 | 2020-09-17 | 4 | Hasara Garrison J. | INTI | Common Stock Option | D | 0,05 | 100.000 | 100.000 | |||||
2020-07-20 | 2020-07-15 | 4 | Mayne Pharma Ventures Pty Ltd | INTI | Common Stock | D | 3.189.688 | 201.842.739 | ||||||
2020-03-24 | 2020-03-20 | 4 | Watson W. Mark | INTI | Common Stock Option | D | 0,05 | 1.500.000 | 1.500.000 | |||||
2020-03-24 | 2020-03-20 | 4 | Martin Robert Daniel | INTI | Common Stock Option | D | 0,05 | 1.000.000 | 1.000.000 | |||||
2020-03-24 | 2020-03-20 | 4 | Peattie Debra | INTI | Common Stock Option | D | 0,05 | 1.000.000 | 1.000.000 | |||||
2020-03-24 | 2020-03-20 | 4 | Ono Richard Dana | INTI | Common Stock Option | D | 0,05 | 1.000.000 | 1.000.000 | |||||
2020-02-10 | 2019-12-12 | 5 | Watson W. Mark | INTI | Common Stock | D | 0,0619 | 500 | 0 | 1.054.100 | ||||
2019-12-16 | 2019-12-12 | 4 | Peattie Debra | INTI | Common Stock Option | D | 0,05 | 210.000 | 210.000 | |||||
2019-12-02 | 2019-12-02 | 4 | Hasara Garrison J. | INTI | Common Stock | D | 0,0700 | 13.500 | 1 | 3.972.544 | ||||
2019-06-10 | 2019-06-03 | 4 | Watson W. Mark | HPPI | Common Stock Option | D | 0,07 | 25.000 | 25.000 | |||||
2019-02-05 | 2019-02-03 | 4 | MAGRAB E. BRENDAN | HPPI | Common Stock Options | D | 0,08 | 986.842 | 986.842 | |||||
2019-02-05 | 2019-02-03 | 4 | Watson W. Mark | HPPI | Common Stock Option | D | 0,08 | 657.895 | 657.895 | |||||
2019-02-05 | 2019-02-03 | 4 | Martin Robert Daniel | HPPI | Common Stock Option | D | 0,08 | 657.895 | 657.895 | |||||
2019-02-05 | 2019-02-03 | 4 | Ono Richard Dana | HPPI | Common Stock Option | D | 0,08 | 657.895 | 657.895 | |||||
2019-01-24 | 2019-01-15 | 4 | Mayne Pharma Ventures Pty Ltd | HPPI | Common Stock | D | 362.121 | 198.653.051 | ||||||
2018-12-26 | 2018-12-20 | 4 | MAGRAB E. BRENDAN | HPPI | Common Stock | D | 0,0800 | 65.000 | 5 | 65.000 | ||||
2018-12-26 | 2018-12-20 | 4 | Martin Robert Daniel | HPPI | Common Stock | D | 0,0800 | 60.000 | 5 | 116.000 | ||||
2018-12-19 | 2018-07-15 | 4 | Mayne Pharma Ventures Pty Ltd | HPPI | Common Stock | D | 184.798 | 198.290.930 | ||||||
2018-08-31 | 2018-08-30 | 4 | Hasara Garrison J. | HPPI | Common Stock | D | 0,2700 | -100.000 | -27 | 3.959.044 | ||||
2018-07-06 | 2018-07-05 | 4 | Mayne Pharma Ventures Pty Ltd | HPPI | Series B Warrants to Purchase Common Stock | D | 0,28 | 1.739.131 | 1.739.131 | |||||
2018-07-06 | 2018-07-05 | 4 | Mayne Pharma Ventures Pty Ltd | HPPI | Series A Warrants to Purchase Common Stock | D | 0,23 | 1.739.131 | 1.739.131 | |||||
2018-07-06 | 2018-07-05 | 4 | Mayne Pharma Ventures Pty Ltd | HPPI | Series B Convertible Preferred Stock | D | 2.318.841 | 5.797.102 | ||||||
2018-03-15 | 2018-03-13 | 4 | Martin Robert Daniel | HPPI | Common Stock Option | D | 0,27 | 56.000 | 56.000 | |||||
2018-03-15 | 2018-03-13 | 4 | Martin Robert Daniel | HPPI | Common Stock Option | D | 0,27 | 253.000 | 253.000 | |||||
2018-03-15 | 2018-03-13 | 4 | MAGRAB E. BRENDAN | HPPI | Common Stock Options | D | 0,27 | 345.000 | 345.000 | |||||
2018-03-15 | 2018-03-13 | 4 | Ono Richard Dana | HPPI | Common Stock Option | D | 0,27 | 56.000 | 56.000 | |||||
2018-03-15 | 2018-03-13 | 4 | Ono Richard Dana | HPPI | Common Stock Option | D | 0,27 | 253.000 | 253.000 | |||||
2018-03-15 | 2018-03-13 | 4 | VIRCA NICHOLAS J | HPPI | Common Stock Option | D | 0,27 | 310.000 | 310.000 | |||||
2018-03-15 | 2018-03-13 | 4 | Hasara Garrison J. | HPPI | Common Stock Option | D | 0,27 | 260.000 | 260.000 | |||||
2018-03-15 | 2018-03-13 | 4 | Watson W. Mark | HPPI | Common Stock Option | D | 0,27 | 76.000 | 76.000 | |||||
2018-03-15 | 2018-03-13 | 4 | Watson W. Mark | HPPI | Common Stock Option | D | 0,27 | 253.000 | 253.000 | |||||
2018-02-12 | 2017-12-19 | 4 | Cross Stefan | HPPI | Common Stock | D | 162.660,0000 | -600.000 | -97.596.000 | 0 | ||||
2018-02-12 | 2017-12-19 | 4 | Mayne Pharma Ventures Pty Ltd | HPPI | Common Stock | D | 162.660,0000 | 600.000 | 97.596.000 | 198.106.132 | ||||
2018-01-11 | 2018-01-10 | 4 | Mayne Pharma Ventures Pty Ltd | HPPI | Series A Warrants to Purchase Common Stock | D | 0,23 | 2.608.696 | 2.608.696 | |||||
2018-01-11 | 2018-01-10 | 4 | Mayne Pharma Ventures Pty Ltd | HPPI | Series B Warrants to Purchase Common Stock | D | 0,28 | 2.608.696 | 2.608.696 | |||||
2018-01-11 | 2018-01-10 | 4 | Mayne Pharma Ventures Pty Ltd | HPPI | Series B Convertible Preferred Stock | D | 3.478.261 | 3.478.261 | ||||||
2017-07-19 | 2017-05-04 | 4 | MAGRAB E. BRENDAN | HPPI | Restricted Stock Units | D | 65.000 | 65.000 | ||||||
2017-07-19 | 2017-05-04 | 4 | Martin Robert Daniel | HPPI | Restricted Stock Units | D | 60.000 | 60.000 | ||||||
2017-07-12 | 2017-06-30 | 4 | HedgePath, LLC | HPPI | Common Stock, $.0001 par value per share | D | -2.500.000 | 79.627.069 | ||||||
2017-03-10 | 2017-03-08 | 4 | Hasara Garrison J. | HPPI | Restricted Stock Units | D | -3.500.000 | 0 | ||||||
2017-03-10 | 2017-03-08 | 4 | Hasara Garrison J. | HPPI | Restricted Stock Units | D | -3.500.000 | 0 | ||||||
2017-03-10 | 2017-03-08 | 4 | Hasara Garrison J. | HPPI | Common Stock | D | 0,3400 | -1.470.478 | -500 | 4.059.044 | ||||
2017-03-10 | 2017-03-08 | 4 | Hasara Garrison J. | HPPI | Common Stock | D | 0,3400 | -1.470.478 | -500 | 4.059.044 | ||||
2017-03-10 | 2017-03-08 | 4 | Hasara Garrison J. | HPPI | Common Stock | D | 3.500.000 | 5.529.522 | ||||||
2017-03-10 | 2017-03-08 | 4 | Hasara Garrison J. | HPPI | Common Stock | D | 3.500.000 | 5.529.522 | ||||||
2017-03-10 | 2017-03-08 | 4 | Watson W. Mark | HPPI | Restricted Stock Units | D | -200.000 | 0 | ||||||
2017-03-10 | 2017-03-08 | 4 | Watson W. Mark | HPPI | Restricted Stock Units | D | -400.000 | 0 | ||||||
2017-03-10 | 2017-03-08 | 4 | Watson W. Mark | HPPI | Restricted Stock Units | D | -300.000 | 0 | ||||||
2017-03-10 | 2017-03-08 | 4 | Watson W. Mark | HPPI | Common Stock | D | 0,3400 | -79.200 | -27 | 553.600 | ||||
2017-03-10 | 2017-03-08 | 4 | Watson W. Mark | HPPI | Common Stock | D | 200.000 | 632.800 | ||||||
2017-03-10 | 2017-03-08 | 4 | Watson W. Mark | HPPI | Common Stock | D | 0,3400 | -158.400 | -54 | 432.800 | ||||
2017-03-10 | 2017-03-08 | 4 | Watson W. Mark | HPPI | Common Stock | D | 400.000 | 591.200 | ||||||
2017-03-10 | 2017-03-08 | 4 | Watson W. Mark | HPPI | Common Stock | D | 0,3400 | -118.800 | -40 | 191.200 | ||||
2017-03-10 | 2017-03-08 | 4 | Watson W. Mark | HPPI | Common Stock | D | 300.000 | 310.000 | ||||||
2017-03-10 | 2017-03-08 | 4 | Ono Richard Dana | HPPI | Restricted Stock Units | D | -150.000 | 0 | ||||||
2017-03-10 | 2017-03-08 | 4 | Ono Richard Dana | HPPI | Restricted Stock Units | D | -300.000 | 0 | ||||||
2017-03-10 | 2017-03-08 | 4 | Ono Richard Dana | HPPI | Restricted Stock Units | D | -300.000 | 0 | ||||||
2017-03-10 | 2017-03-08 | 4 | Ono Richard Dana | HPPI | Common Stock | D | 0,3400 | -59.400 | -20 | 453.000 | ||||
2017-03-10 | 2017-03-08 | 4 | Ono Richard Dana | HPPI | Common Stock | D | 150.000 | 512.400 | ||||||
2017-03-10 | 2017-03-08 | 4 | Ono Richard Dana | HPPI | Common Stock | D | 0,3400 | -118.800 | -40 | 362.400 | ||||
2017-03-10 | 2017-03-08 | 4 | Ono Richard Dana | HPPI | Common Stock | D | 0,3400 | -118.800 | -40 | 362.400 | ||||
2017-03-10 | 2017-03-08 | 4 | Ono Richard Dana | HPPI | Common Stock | D | 300.000 | 481.200 | ||||||
2017-03-10 | 2017-03-08 | 4 | Ono Richard Dana | HPPI | Common Stock | D | 300.000 | 481.200 | ||||||
2017-03-10 | 2017-03-08 | 4 | Cross Stefan | HPPI | Restricted Stock Units | D | -300.000 | 0 | ||||||
2017-03-10 | 2017-03-08 | 4 | Cross Stefan | HPPI | Restricted Stock Units | D | -300.000 | 0 | ||||||
2017-03-10 | 2017-03-08 | 4 | Cross Stefan | HPPI | Common Stock | D | 300.000 | 600.000 | ||||||
2017-03-10 | 2017-03-08 | 4 | Cross Stefan | HPPI | Common Stock | D | 300.000 | 600.000 | ||||||
2017-03-10 | 2017-03-08 | 4 | VIRCA NICHOLAS J | HPPI | Restricted Stock Units | D | -15.041.738 | 0 | ||||||
2017-03-10 | 2017-03-08 | 4 | VIRCA NICHOLAS J | HPPI | Common Stock | D | 0,3400 | -6.314.219 | -2.147 | 8.727.519 | ||||
2017-03-10 | 2017-03-08 | 4 | VIRCA NICHOLAS J | HPPI | Common Stock | D | 15.041.738 | 15.041.738 | ||||||
2016-11-15 | 2016-11-15 | 4 | Mayne Pharma Ventures Pty Ltd | HPPI | Warrant to Purchase Common Stock | D | 0,12 | -4.860.000 | 23.504.236 | |||||
2016-11-15 | 2016-11-15 | 4 | Mayne Pharma Ventures Pty Ltd | HPPI | Warrant to Purchase Common Stock | D | 0,08 | -333 | 0 | |||||
2016-11-15 | 2016-11-15 | 4 | Mayne Pharma Ventures Pty Ltd | HPPI | Warrant to Purchase Common Stock | D | 0,09 | -4.750.569 | 0 | |||||
2016-11-15 | 2016-11-15 | 4 | Mayne Pharma Ventures Pty Ltd | HPPI | Common Stock | D | 4.860.000 | 197.506.132 | ||||||
2016-11-15 | 2016-11-15 | 4 | Mayne Pharma Ventures Pty Ltd | HPPI | Common Stock | D | 333 | 192.646.132 | ||||||
2016-11-15 | 2016-11-15 | 4 | Mayne Pharma Ventures Pty Ltd | HPPI | Common Stock | D | 4.750.569 | 192.645.799 | ||||||
2016-11-07 | 2016-11-04 | 4 | Mayne Pharma Ventures Pty Ltd | HPPI | Warrant to Purchase Common Stock | D | 0,08 | -33.333.000 | 333 | |||||
2016-11-07 | 2016-11-04 | 4 | Mayne Pharma Ventures Pty Ltd | HPPI | Warrant to Purchase Common Stock | D | 0,09 | -5.500.000 | 4.750.569 | |||||
2016-11-07 | 2016-11-04 | 4 | Mayne Pharma Ventures Pty Ltd | HPPI | Common Stock | D | 33.333.000 | 187.895.230 | ||||||
2016-11-07 | 2016-11-04 | 4 | Mayne Pharma Ventures Pty Ltd | HPPI | Common Stock | D | 5.500.000 | 154.562.230 | ||||||
2016-07-06 | 2016-07-01 | 4 | SEARS SAMUEL P JR | HPPI | Options to Purchase Common Stock | D | 0,24 | 150.000 | 150.000 | |||||
2016-07-06 | 2016-07-01 | 4 | SEARS SAMUEL P JR | HPPI | Restricted Stock Units | D | 150.000 | 150.000 | ||||||
2016-07-06 | 2016-07-01 | 4 | Ono Richard Dana | HPPI | Restricted Stock Units | D | 150.000 | 150.000 | ||||||
2016-07-06 | 2016-07-01 | 4 | Ono Richard Dana | HPPI | Options to Purchase Common Stock | D | 0,24 | 150.000 | 150.000 | |||||
2016-07-06 | 2016-07-01 | 4 | Watson W. Mark | HPPI | Restricted Stock Units | D | 200.000 | 200.000 | ||||||
2016-07-06 | 2016-07-01 | 4 | Watson W. Mark | HPPI | Options to Purchase Common Stock | D | 0,24 | 200.000 | 200.000 | |||||
2016-06-20 | 2016-06-15 | 4/A | ODONNELL FRANCIS E JR By Hopkins Capital Group II, LLC | HPPI | Common Stock, $.0001 par value per share | I | 2.560.000 | 16.560.000 | ||||||
2016-06-20 | 2016-06-15 | 4 | HedgePath, LLC | HPPI | Common Stock, $.0001 par value per share | D | -2.560.000 | 82.127.069 | ||||||
2016-06-17 | 2016-06-15 | 4 | ODONNELL FRANCIS E JR By Hopkins Capital Group II, LLC | HPPI | Common Stock, $.0001 par value per share | I | -2.560.000 | 11.440.000 | ||||||
2016-06-08 | 2016-06-06 | 4 | ODONNELL FRANCIS E JR By Hopkins Capital Group II, LLC | HPPI | Common Stock, $.0001 par value per share | I | -6.000.000 | 14.000.000 | ||||||
2016-05-27 | 2016-05-25 | 4 | Mayne Pharma Group Ltd Footnote | HPPI* | Warrant to Purchase Common Stock | I | 0,01 | 28.364.236 | 71.948.138 | |||||
2016-05-27 | 2016-05-25 | 4 | Mayne Pharma Group Ltd Footnote | HPPI* | Common Stock | I | 27.885.000 | 149.062.230 | ||||||
2015-09-14 | 2015-09-10 | 4 | ODONNELL FRANCIS E JR By Hopkins Capital Group II, LLC | HPPI | Common Stock, $.0001 par value per share | I | 20.000.000 | 20.000.000 | ||||||
2015-09-14 | 2015-09-10 | 4 | HedgePath, LLC | HPPI | Common Stock, $.0001 par value per share | D | -20.000.000 | 84.687.069 | ||||||
2015-09-14 | 2014-08-14 | 4 | HedgePath, LLC | HPPI | Common Stock, $.0001 par value per share | D | 82.156.842 | 104.687.069 | ||||||
2015-08-18 | 2015-08-14 | 4 | Cross Stefan | HPPI | Restricted Stock Units | D | 300.000 | 300.000 | ||||||
2015-08-18 | 2015-08-14 | 4 | Ono Richard Dana | HPPI | Restricted Stock Units | D | 300.000 | 300.000 | ||||||
2015-08-18 | 2015-08-14 | 4 | SEARS SAMUEL P JR | HPPI | Restricted Stock Units | D | 300.000 | 300.000 | ||||||
2015-08-18 | 2015-08-14 | 4 | Watson W. Mark | HPPI | Restricted Stock Units | D | 400.000 | 400.000 | ||||||
2015-05-19 | 2015-05-15 | 4 | Mayne Pharma Group Ltd Footnote | HPPI | Warrant to Purchase Common Stock | I | 0,08 | 33.333.333 | 43.583.902 | |||||
2015-05-19 | 2015-05-15 | 4 | Mayne Pharma Group Ltd Footnote | HPPI | Common Stock | I | 33.333.333 | 121.177.230 | ||||||
2015-02-06 | 2014-07-18 | 5 | VIRCA NICHOLAS J | HPPI | Restricted Stock Units | D | 15.041.738 | 15.041.738 | ||||||
2015-02-06 | 2014-08-06 | 5 | Hasara Garrison J. | HPPI | Restricted Stock Units | D | 3.500.000 | 3.500.000 | ||||||
2015-02-06 | 2014-08-06 | 5 | Hasara Garrison J. | HPPI | Restricted Stock Units | D | 3.500.000 | 3.500.000 | ||||||
2015-02-06 | 2014-07-18 | 5 | Cross Stefan | HPPI | Restricted Stock Units | D | 300.000 | 300.000 | ||||||
2015-02-06 | 2014-07-18 | 5 | SEARS SAMUEL P JR | HPPI | Restricted Stock Units | D | 300.000 | 300.000 | ||||||
2015-02-06 | 2014-07-18 | 5 | Ono Richard Dana | HPPI | Restricted Stock Units | D | 300.000 | 300.000 | ||||||
2015-02-06 | 2014-07-18 | 5 | Watson W. Mark | HPPI | Restricted Stock Units | D | 300.000 | 300.000 | ||||||
2014-09-09 | 2014-09-08 | 4 | Watson W. Mark | HPPI | Common Stock | D | 0,1300 | 10.000 | 1 | 10.000 | ||||
2014-07-09 | 2014-06-24 | 4 | ODONNELL FRANCIS E JR By Trust | HPPI | Series A Convertible Preferred Stock | I | 18.984 | 64.034 | ||||||
2014-07-09 | 2014-06-24 | 4 | ODONNELL FRANCIS E JR By Hedgepath LLC | HPPI | Series A Convertible Preferred Stock | I | 4.012 | 13.532 | ||||||
2014-07-09 | 2014-06-24 | 4 | ODONNELL FRANCIS E JR By Trust | HPPI | Warrant to purchase Common Stock | I | 0,88 | 2.716.401 | 2.716.401 | |||||
2014-07-09 | 2014-06-24 | 4 | ODONNELL FRANCIS E JR By Hedgepath LLC | HPPI | Warrant to purchase Common Stock | I | 0,88 | 574.032 | 574.032 | |||||
2014-07-09 | 2014-06-24 | 4 | ODONNELL FRANCIS E JR By Trust | HPPI | Common Stock, $.0001 par value per share | I | 670.510 | 670.510 | ||||||
2014-07-09 | 2014-06-24 | 4 | ODONNELL FRANCIS E JR By Hedgepath LLC | HPPI | Common Stock, $.0001 par value per share | I | 141.693 | 141.693 | ||||||
2014-07-09 | 2014-06-24 | 4 | ODONNELL FRANCIS E JR By Trust | HPPI | Common Stock, $.0001 par value per share | I | 0,0750 | 5.300.000 | 398 | 5.970.510 | ||||
2014-07-09 | 2014-06-24 | 4 | ODONNELL FRANCIS E JR By Hedgepath LLC | HPPI | Common Stock, $.0001 par value per share | I | 0,0750 | 1.120.000 | 84 | 1.261.693 | ||||
2014-07-09 | 2014-06-24 | 4 | HedgePath, LLC | HPPI | Series A Convertible Preferred Stock | D | 71.636 | 241.637 | ||||||
2014-07-09 | 2014-06-24 | 4 | HedgePath, LLC | HPPI | Warrant to purchase Common Stock | D | 0,88 | 10.250.569 | 10.250.569 | |||||
2014-07-09 | 2014-06-24 | 4 | HedgePath, LLC | HPPI | Common Stock, $.0001 par value per share | D | 2.530.227 | 2.530.227 | ||||||
2014-07-09 | 2014-06-24 | 4 | HedgePath, LLC | HPPI | Common Stock, $.0001 par value per share | D | 0,0750 | 20.000.000 | 1.500 | 22.530.227 | ||||
2014-06-26 | 2014-06-24 | 4 | Mayne Pharma Ventures Pty Ltd | CBTEQ | Common Stock Purchase Warrant | D | 0,09 | 1 | 1 | |||||
2014-06-26 | 2014-06-24 | 4 | Mayne Pharma Ventures Pty Ltd | CBTEQ | Series A Convertible Preferred Stock | D | 258.363 | 258.363 | ||||||
2013-08-16 | 2013-08-13 | 4 | ODONNELL FRANCIS E JR By Trust | CBTEQ | Series A Convertible Preferred Stock | I | 45.050 | 45.050 | ||||||
2013-08-16 | 2013-08-13 | 4 | ODONNELL FRANCIS E JR By HedgePath, LLC | CBTEQ | Series A Convertible Preferred Stock | I | 9.520 | 9.520 | ||||||
2013-08-16 | 2013-08-13 | 4 | HedgePath, LLC | CBTEQ | Series A Convertible Preferred Stock | D | 170.001 | 170.001 | ||||||
2013-04-19 | 2013-04-12 | 4 | FREER RICHARD J | CBTEQ | Common Stock | D | 0,0457 | 2.846.715 | 130 | 7.485.141 | ||||
2013-04-19 | 2013-04-12 | 4 | SEARS SAMUEL P JR | CBTEQ | Common Stock | D | 0,0457 | 372.263 | 17 | 1.016.096 | ||||
2012-09-07 | 2012-08-22 | 4 | FREER RICHARD J | CBTEQ | Common Stock | D | 0,0200 | 2.025.000 | 40 | 4.638.426 | ||||
2005-03-22 | 2005-03-22 | 4 | CAUSEY JAMES D | CBTE | Common Stock | D | 4,2390 | 1.000 | 4 | 1.000 | ||||
2005-01-06 | 2005-01-03 | 4 | EINSELEN PETER C | CBTE | Options | D | 6,00 | 6,0000 | 3.000 | 18 | 3.000 | |||
2005-01-04 | 2005-01-03 | 4 | Krueger Gerald P | CBTE | Options | D | 6,00 | 6,0000 | 3.000 | 18 | 3.000 | |||
2005-01-04 | 2004-11-05 | 4 | Krueger Gerald P | CBTE | Options | D | 5,80 | 5,8000 | 5.000 | 29 | 18.000 | |||
2005-01-04 | 2004-11-05 | 4 | Krueger Gerald P | CBTE | Options | D | 5,80 | 5,8000 | 5.000 | 29 | 13.000 | |||
2005-01-04 | 2004-11-05 | 4 | Krueger Gerald P | CBTE | Options | D | 5,80 | 5,8000 | 5.000 | 29 | 8.000 | |||
2004-09-17 | 3 | Krueger Gerald P | CBTE | Common Stock | D | 0 | ||||||||
2003-12-01 | 2003-08-08 | 4 | CAUSEY JAMES D | CBTE | Options | D | 2,42 | 15.000 | 15.000 |